Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals

HEMASPHERE

LIPPINCOTT WILLIAMS & WILKINS

1. IEMBITHEK (Greece)